MM
Manish Mathuradas Dhame
About Manish Mathuradas Dhame
Data last updated:
Manish Mathuradas Dhame is a Director at Yuvak Prerna Foundation (since 2022). The companies operate in Non-Profit Organizations. Yuvak Prerna Foundation reported revenue of ₹2,322 (FY 2025). Earlier, Manish Mathuradas Dhame was a Director at Ehem Pharmachem Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Yuvak Prerna Foundation U85300MH2022NPL383132 | Director | 23 May 2022 | 2022 | ₹2,322 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ehem Pharmachem Private Limited U24239MH2008PTC186042 | Director | 21 Aug 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manish Mathuradas Dhame
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Babubhai Trivedi | 09615008 | Yuvak Prerna Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Mathuradas Dhame
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Mathuradas Dhame
Manish Mathuradas Dhame currently holds 1 directorship: Yuvak Prerna Foundation (Director, since 23 May 2022, revenue ₹2,322 (FY 2025)).
Manish Mathuradas Dhame was first appointed on 21 Aug 2008 as Director at Ehem Pharmachem Private Limited. The most recent appointment on record is 23 May 2022 at Yuvak Prerna Foundation.
Manish Mathuradas Dhame held 1 earlier board appointment: Ehem Pharmachem Private Limited (Director, from 21 Aug 2008).
The current boards of Manish Mathuradas Dhame's companies include Ajay Babubhai Trivedi (Yuvak Prerna Foundation).